Major Shareholder Sells Corbus Pharmaceuticals Stock
1 report, 1 independent
Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cormorant Asset Management, Lp sold 425,000 shares of Corbus Pharmaceuticals stock on October 29th, for a total value of $1,742,500.00. This transaction, disclosed with the SEC, represented an 18.12% decrease in the firm's ownership of the company.
From themarketsdaily.com
Why it matters
The sale by a major shareholder occurred while Corbus Pharmaceuticals stock was trading down. This follows a recent quarterly earnings report where the company reported ($1.81) earnings per share, missing the consensus estimate of ($1.26).
From themarketsdaily.com
Who's involved
- Corbus PharmaceuticalsCompany whose stock was sold
- Pale Fire CapitalExecuted a specific investment action by lifting its position in Corbus Pharmaceuticals stock
Keep exploring
The entities involved
-
Corbus Pharmaceuticals
company in Norwood, United States
Nothing else this week.
-
Pale Fire Capital
Czech private equity company
Nothing else this week.